1. Home
  2. MPV vs HUMA Comparison

MPV vs HUMA Comparison

Compare MPV & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barings Participation Investors

MPV

Barings Participation Investors

HOLD

Current Price

$16.35

Market Cap

169.4M

Sector

Finance

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

BUY

Current Price

$0.47

Market Cap

165.7M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
MPV
HUMA
Founded
1988
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
169.4M
165.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MPV
HUMA
Price
$16.35
$0.47
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
★ $1.85
AVG Volume (30 Days)
17.2K
★ 3.2M
Earning Date
01-01-0001
11-11-2026
Dividend Yield
★ 8.71%
N/A
EPS Growth
N/A
★ 79.37
EPS
★ 1.71
N/A
Revenue
N/A
★ $2,038,000.00
Revenue This Year
N/A
$72.32
Revenue Next Year
N/A
$518.79
P/E Ratio
$9.56
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.05
$0.47
52 Week High
$20.58
$1.90

Technical Indicators

Market Signals
Indicator
MPV
HUMA
Relative Strength Index (RSI) 47.66 27.19
Support Level $16.14 N/A
Resistance Level $17.38 $0.75
Average True Range (ATR) 0.52 0.03
MACD -0.04 -0.01
Stochastic Oscillator 48.84 6.40

Price Performance

Historical Comparison
MPV
HUMA

About MPV Barings Participation Investors

Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: